Assisted Reproductive Technology Market: Growth, Size, Share, and Trends

Report Code MD 9335
Published in Mar, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Assisted Reproductive Technology Market by Technology (In Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030

US Tariff Impact on Assisted Reproductive Technology Market

Trump Tariffs Are Reshaping Global Business

Overview

The global assisted reproductive technology market, valued at US$4.02 billion in 2024, is forecasted to grow at a robust CAGR of 7.0%, reaching US$4.29 billion in 2025 and an impressive US$6.02 billion by 2030. The assisted reproductive technology market has been segmented by type, technology, patient type, care settings, and region. Increased levels of infertility caused by stress, lifestyle changes, and medical conditions are among the key drivers affecting the assisted reproductive technology (ART) market. The sector has expanded due to technological advancements such as preimplantation genetic testing (PGT), embryo freezing, and enhanced in-vitro fertilization (IVF) techniques that have significantly improved success rates. Industry growth is prevented by ethical and regulatory issues, including legal bans, expensive processes, and the ethical debate over the handling of embryos and surrogacy. Government backing from the state, a change in social perception, and rising public awareness all drive market growth. Improved healthcare infrastructure and greater disposable incomes in the developing world can spur developments in ART therapy.

Assisted Reproductive Technology Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Assisted Reproductive Technology Market

Asia Pacific

The Asia Pacific region is expected to grow at the highest CAGR of 7.9% during the forecast period owing to the increasing infertility rates, rising awareness of fertility treatments, and improving healthcare infrastructure. Factors such as changing lifestyles, delayed pregnancies, and stress-related fertility issues are driving demand for ART procedures in the region.

Growth in this market is mainly driven by the increasing median age of pregnancy, rising infertility rate, booming fertility industry and volving technological landscape.

High cost of IVF procedures, Social and ethical concerns in developing countries, and elevated risk of complications

The Asia Pacific market is projected to reach USD 2,196.4 million by 2030 during the forecast period.

The high healthcare expenditure, growth opportunities in emerging economies, availability of diverse range of fertility treatment options are expected to offer lucrative growth opportunities for market players.

Global Assisted Reproductive Technology Market Dynamics

DRIVER: Rising Infertility Rate

Around 17.5% of the adult population, roughly 1 in 6 worldwide, experience infertility, highlighting the urgent need to improve access to affordable, high-quality fertility care for those in need during April 2023 (Source: WHO). While the WHO previously estimated (in 2010) that 48.5 million people worldwide were affected by infertility, current estimates (2023) suggest that up to 186 million individuals worldwide may be impacted. Nonetheless, there are geographical differences in the cause and prevalence of infertility, as well as restricted access to ART. Untreated sexually transmitted infections, post-abortion, and postpartum infections are the main reasons for the high prevalence of infertility in Sub-Saharan Africa.

RESTRAINT: Social and ethical concerns in developing countries

While governments in some countries depend on government advice, others have established a legislative framework to address legal concerns related to reproductive treatment. The regulations of fertility treatments vary widely from country to country; those that are permissible in one can be entirely prohibited in another. In less developed countries, IVF treatment has raised ethical and social issues. These conditions, like access issues precipitated by cost, foster inequality. Religious and cultural perspectives may enhance ethical issues in the use of donor gametes, spare embryos, and embryo choice.

 

OPPORTUNITY: Growth Opportunities in Emerging Economies

There are a number of reasons why the medical tourism industry is thriving in developing countries. Most doctors and surgeons in Asia have their training and education at top-level institutions in Europe and the US, and medical facilities are of high standard and treatment procedures are reasonably affordable.

Brazil boasts over 20 medical facilities and around 150 facilities offering infertility treatment. In the US, an IVF cycle will cost around $12,000, whereas in Brazil, the same can be completed for around $4,000. India is among the cheapest places in the world to have IVF and other infertility treatments, with more than 500 individual IVF centers. In the US, a cycle of IVF will cost around $12,000, but in India, the same can be completed for between $2,000 and $3,000.

CHALLENGES: Reduced efficacy of infertility treatments for patients of advanced age

More and more older women are now seeking the help of infertility clinics due to the changing social environment. It will take women longer to get pregnant with increasing age, and the likelihood of not getting pregnant also increases. Moreover, as mothers increase in age, so do the issues during pregnancy and labor. 35 years or above is generally considered to be advanced maternal age. With increasing age, individuals often suffer from a decline in fertility, which may restrict their ability to become pregnant. Pregnant women whose partners are 45 years or older are 28% more likely to develop gestational diabetes, as per research. Premature birth, low blood sugar at birth, bigger babies, and a greater risk of developing type 2 diabetes as an adult are all outcomes of this.

Global Assisted Reproductive Technology Market Ecosystem Analysis

The ecosystem of the assisted reproductive technology market comprises elements present in this market and defines these elements with a demonstration of the bodies involved. It includes manufacturers, distributors, research & product developers, and end users.

Manufacturers include organizations involved in research, design, product development, optimization, and launch. Distributors include third parties and e-commerce sites linked to the organization for the marketing of medical devices. Research & product developers include in-house research facilities, contract research organizations, and contract development & manufacturing organizations, which play an important role in outsourcing research for product development. End users include patients who use assisted reproductive technology. On the other hand, investors/funders and health regulatory bodies are the major influencers in this market.

Assisted Reproductive Technology Market Ecosystem
 

The IVF segment to grow with highest CAGR in the forecast period, by technology

Owing to constant technological advancements, increasing rates of infertility, and greater awareness about fertility treatments, the in-vitro fertilization (IVF) segment is expected to register the highest CAGR during the forecast period in the ART market. Time-lapse imaging, artificial intelligence-based embryo selection, and improved cryopreservation techniques are a few of the technologies that are boosting IVF success rates and making it the preferred treatment for patients. The sector is also expanding due to drivers such as delayed childbearing, reproductive issues associated with lifestyle factors, and increasing government support for ART treatments.

The media segment to grow with highest CAGR in the forecast period, by type

As a result of the increasing need for high-end culture media, sperm-washing media, and cryopreservation media utilized in assisted reproductive treatments, the media segment is expected to grow at the highest CAGR in the ART market during the forecast period. Advances in media formulations, including embryo culture media supplemented with growth factors and antioxidants, are dramatically enhancing embryo survivability and implantation rates. Since greater emphasis is being placed on maximizing in-vitro environments for embryo development and maximizing ART success rates, the demand for innovative media solutions will be greater in the next few years.

The Asia Pacific region is projected to register the highest growth rate during the forecast period.

The Asia Pacific market is expected to witness the highest compound annual growth rate (CAGR) of the ART market over the forecast period because of the growing incidence of infertility, greater awareness about fertility treatments, and the availability of reproductive technologies. The market is witnessing growth in medical tourism because countries such as Malaysia, Thailand, and India offer high-quality but affordable ART treatment. The market is also expanding due to rising fertility clinics, improving healthcare infrastructure, and promotion of government initiatives such as ART procedure subsidization and regulatory approvals. Additionally, advancements in genetic screening and cryopreservation technologies will continue to drive the ART market's explosive growth in Asia Pacific.

CHINA FASTEST-GROWING MARKET IN THE REGION
ASIA PACIFIC FASTEST GROWING MARKET IN THE REGION
Assisted Reproductive Technology Market Region

Recent Developments of Assisted Reproductive Technology Market

  • In January 2025, FUJIFILM Irvine Scientific agreed to sell its Medical Media Business Unit (MBU) to Astorg, aligning with its focus on life sciences. This divestiture enables the company to strengthen its core offerings in innovative and accessible therapies.
  • In May 2024, Vitrolife acquired eFertility to enhance standardization and digitalization in IVF clinics globally.
  • In June 2024, CooperSurgical Inc. acquired ZyMot Fertility, a subsidiary of DxNow, Inc. The sperm separation device of ZyMot Fertility will add to the CooperSurgical Inc. portfolio of ART products and services.
  • In May 2023, Genea BIOMEDX and AIVF partnered to create a suite of AI-based solutions to enhance the efficiency and success rates of IVF clinics

Key Market Players

KEY PLAYERS IN THE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Assisted Reproductive Technology Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD Million)
Segments covered By Technology, Type, Patient Type, Care Setting and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

 

Key Questions Addressed by the Report

Who are the leading industry players in the assisted reproductive technology market?
The key players in this market are CooperSurgical Inc. (US), FUJIFILM Irvine Scientific (Japan), Vitrolife (Sweden), Hamilton Thorne (US), and Cook Medical Inc. (US).
Which technology segments have been included in the assisted reproductive technology market report?
The report includes the following technology segments: IVF and Artificial Insemination.
Which region dominated the assisted reproductive technology market in 2024?
In 2024, the Asia Pacific region accounted for the largest share of the assisted reproductive technology market.
What are the emerging trends in the assisted reproductive technology market?
Key trends include the integration of AI and machine learning for embryo selection and success rate prediction, the growing popularity of fertility preservation (egg and sperm freezing), and the rise of medical tourism for affordable reproductive treatments in countries like Spain, Thailand, and India.
What is the total CAGR expected for the assisted reproductive technology market during 2025−2030?
The assisted reproductive technology market is expected to grow at a CAGR of 7.0% during the forecast period.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Assisted Reproductive Technology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
50
PREMIUM INSIGHTS
55
MARKET OVERVIEW
60
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing median age of pregnancy
    - Rising infertility rate
    - Booming fertility industry
    - Evolving technological landscape
    - Favorable government initiatives
    RESTRAINTS
    - High cost of IVF procedures
    - Social and ethical concerns in developing countries
    - Elevated risk of complications
    OPPORTUNITIES
    - Growth opportunities in emerging economies
    - Availability of diverse range of fertility treatment options
    CHALLENGES
    - Reduced efficacy of infertility treatments for patients of advanced age
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS
    AVERAGE SELLING PRICE TREND, BY REGION
  • 5.5 VALUE CHAIN ANALYSIS
    RESEARCH & PRODUCT DEVELOPMENT
    RAW MATERIAL PROCUREMENT AND MANUFACTURING
    DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
  • 5.6 SUPPLY CHAIN ANALYSIS
    PROMINENT COMPANIES
    SMALL AND MEDIUM-SIZED ENTERPRISES
    END USERS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Time-lapse technology
    COMPLEMENTARY TECHNOLOGIES
    - Preimplantation genetic testing
    ADJACENT TECHNOLOGIES
    - Sperm cryopreservation
    - Oocyte cryopreservation
  • 5.10 PATENT ANALYSIS
  • 5.11 TRADE DATA ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.12 KEY CONFERENCES AND EVENTS, 2025–2026
  • 5.13 CASE STUDY ANALYSIS
    CASE STUDY 1: ENHANCED IVF RATES USING EMBRYOTOXICITY, PLATELET LEUKOCYTE AGGREGATES, AND NATURAL KILLER DIAGNOSIS
    CASE STUDY 2: IMPROVED EMBRYO SELECTION THROUGH AI-DRIVEN PLATFORM
    CASE STUDY 3: ASSESSMENT OF EMBRYO VIABILITY USING AI-DRIVEN SYSTEMS
  • 5.14 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
  • 5.15 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.17 UNMET NEEDS
  • 5.18 REIMBURSEMENT SCENARIO
  • 5.19 IMPACT OF AI/GEN AI ON ASSISTED REPRODUCTIVE TECHNOLOGY MARKET
    INTRODUCTION
    MARKET POTENTIAL OF AI IN ASSISTED REPRODUCTIVE TECHNOLOGY
    AI USE CASES
    KEY COMPANIES IMPLEMENTING AI
    FUTURE OF GENERATIVE AI IN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET
ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE
101
  • 6.1 INTRODUCTION
  • 6.2 IN VITRO FERTILIZATION
    IVF WITH ICSI
    - Higher success rates than conventional methods to stimulate growth
    IVF WITHOUT ICSI
    - Preferred choice for less severe infertility issues to facilitate growth
  • 6.3 ARTIFICIAL INSEMINATION
    GROWING PREFERENCE FOR MINIMALLY INVASIVE TREATMENTS TO DRIVE MARKET
ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE
107
  • 7.1 INTRODUCTION
  • 7.2 INSTRUMENTS
    EMBRYO INCUBATORS
    - Need for undisturbed and protective environment throughout incubation to aid growth
    SPERM ANALYZER SYSTEMS
    - Capability to identify fertility problems and determine appropriate interventions to fuel market
    MICROMANIPULATORS
    - Increased adoption of micromanipulators in intracytoplasmic sperm injections and embryo biopsies to boost market
    OTHER INSTRUMENTS
  • 7.3 MEDIA
    EMBRYO CULTURE MEDIA
    - Close resemblance to natural environment to amplify growth
    CRYOPRESERVATION MEDIA
    - Ability to protect cells from damage to drive market
    SEMEN PROCESSING MEDIA
    - Growing application in washing, capacitation, and sperm selection to boost market
    OVUM PROCESSING MEDIA
    - Ability to mimic natural conditions of female reproductive tract to aid growth
  • 7.4 SUPPLEMENTS
    RISING DEMAND FOR FERTILITY-ENHANCING SUPPLEMENTS TO SUPPORT GROWTH
  • 7.5 CONSUMABLES
    CULTURE DISHES & PLATES
    - Growing advancements in embryo incubation to drive market
    STORAGE CONTAINERS
    - Increasing use of cryopreservation techniques to expedite growth
    CRYOVIALS & TUBES
    - Growing trend of egg and embryo freezing for delayed parenthood to boost market
    OTHER CONSUMABLES
ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE
129
  • 8.1 INTRODUCTION
  • 8.2 FEMALE PATIENTS
    RISING FEMALE INFERTILITY RATE TO AMPLIFY GROWTH
  • 8.3 MALE PATIENTS
    LIFESTYLE CHANGES AND INCREASING INCIDENCE OF LOW SPERM COUNT TO PROMOTE GROWTH
ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER
133
  • 9.1 INTRODUCTION
  • 9.2 FERTILITY CLINICS
    INCREASED AVAILABILITY AND ACCESSIBILITY OF FERTILITY CLINICS TO SUSTAIN GROWTH
  • 9.3 HOSPITALS & SURGERY CLINICS
    NEED FOR ADVANCED LABORATORIES FOR GAMETE HANDLING AND ULTRASOUND MONITORING TO AID GROWTH
  • 9.4 RESEARCH INSTITUTES
    ONGOING RESEARCH FOR COST-EFFECTIVE AND ADVANCED TECHNIQUES TO STIMULATE GROWTH
  • 9.5 CRYOBANKS
    GROWING INCLINATION TOWARD FLEXIBLE TREATMENT TO FUEL MARKET
ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION
140
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Favorable infrastructure network to encourage growth
    CANADA
    - Growing assistance from banks for fertility treatments to fuel market
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Robust healthcare infrastructure to support growth
    UK
    - Increasing focus on high-quality care at licensed fertility clinics to propel market
    FRANCE
    - Growing healthcare expenditure to boost market
    ITALY
    - Favorable regulatory guidelines to support market growth
    SPAIN
    - Booming medical tourism to drive market
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Increasing medical benefits for childbirth to intensify growth
    JAPAN
    - Low fertility rates to amplify growth
    INDIA
    - Affordable treatment options to favor growth
    AUSTRALIA
    - Declining fertility rate to advance growth
    SOUTH KOREA
    - Growing focus on reversing low population trend to drive market
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Rise in aging mothers to contribute to growth
    MEXICO
    - Growing network of state-of-the-art facilities to boost market
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    RISING HEALTHCARE SPENDING TO FOSTER GROWTH
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.7 GCC COUNTRIES
    IMPROVED HEALTH INFRASTRUCTURE AND BETTER AWARENESS ABOUT FERTILITY TREATMENTS TO PROPEL MARKET
    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
COMPETITIVE LANDSCAPE
245
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET
  • 11.3 REVENUE ANALYSIS, 2020–2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 11.6 BRAND/PRODUCT COMPARISON
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Type footprint
    - Product type footprint
    - Patient type footprint
    - End-user footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
266
  • 12.1 KEY PLAYERS
    COOPERSURGICAL INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    FUJIFILM IRVINE SCIENTIFIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    VITROLIFE
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - MnM view
    COOK MEDICAL INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    HAMILTON THORNE
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    KITAZATO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    ESCO MICRO PTE. LTD.
    - Business overview
    - Products offered
    - Recent developments
    FERTIPRO NV
    - Business overview
    - Products offered
    GENEA BIOMEDX
    - Business overview
    - Products offered
    - Recent developments
    LENUS PHARMA GESMBH
    - Business overview
    - Products offered
    - Recent developments
    ZITA WEST
    - Business overview
    - Products offered
    EXELTIS USA, INC.
    - Business overview
    - Products offered
    VITABIOTICS LTD.
    - Business overview
    - Products offered
    ADVACARE PHARMA
    - Business overview
    - Products offered
  • 12.2 OTHER COMPANIES
    FAIRHAVEN HEALTH
    SHANGHAI UNICORN MEDICAL TECHNOLOGY CO., LTD.
    GYNEMED GMBH & CO. KG
    INVITROCARE INC.
    IVFTECH
    LABIVF ASIA PTE LTD.
    COAST SCIENCE
    BIOIMAGER INC.
    SHIVANI SCIENTIFIC
    MINITÜB GMBH
APPENDIX
312
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2019–2023
  • TABLE 3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE, 2022–2024 (USD)
  • TABLE 4 AVERAGE SELLING PRICE TREND OF SUPPLEMENTS, BY REGION, 2022–2024 (USD)
  • TABLE 5 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 6 INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024
  • TABLE 7 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND)
  • TABLE 8 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND)
  • TABLE 9 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
  • TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 REGULATORY STANDARDS AND APPROVALS FOR ASSISTED REPRODUCTIVE TECHNOLOGY
  • TABLE 16 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS (%)
  • TABLE 18 KEY BUYING CRITERIA FOR TOP TWO END USERS
  • TABLE 19 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: CURRENT UNMET NEEDS
  • TABLE 20 MAJOR CPT CODES FOR LASER PROCEDURES IN US, 2024
  • TABLE 21 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 22 ASSISTED REPRODUCTIVE TYPE MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 23 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 24 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF WITH ICSI, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 25 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF WITHOUT ICSI, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 26 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR ARTIFICIAL INSEMINATION, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 27 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 28 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 29 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 30 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR EMBRYO INCUBATORS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 31 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR EMBRYO INCUBATORS, BY REGION, 2022–2030 (THOUSAND UNITS)
  • TABLE 32 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR SPERM ANALYZER SYSTEMS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 33 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR SPERM ANALYZER SYSTEMS, BY REGION, 2022–2030 (THOUSAND UNITS)
  • TABLE 34 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MICROMANIPULATORS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 35 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MICROMANIPULATORS, BY REGION, 2022–2030 (THOUSAND UNITS)
  • TABLE 36 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 37 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 38 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 39 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR EMBRYO CULTURE MEDIA, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 40 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CRYOPRESERVATION MEDIA, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 41 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR SEMEN PROCESSING MEDIA, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 42 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR OVUM PROCESSING MEDIA, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 43 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR SUPPLEMENTS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 44 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 45 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 46 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CULTURE DISHES & PLATES, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 47 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR STORAGE CONTAINERS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 48 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CRYOVIALS & TUBES, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 49 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 50 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 51 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 52 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 53 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 54 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR FERTILITY CLINICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 55 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR HOSPITALS & SURGERY CLINICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 56 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 57 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CRYOBANKS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 58 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 59 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 68 US: KEY MACROECONOMIC INDICATORS
  • TABLE 69 US: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 70 US: IVF ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 71 US: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 72 US: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 73 US: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 74 US: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 75 US: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 76 US: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 77 CANADA: KEY MACROECONOMIC INDICATORS
  • TABLE 78 CANADA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 79 CANADA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 80 CANADA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 81 CANADA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 82 CANADA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 83 CANADA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 84 CANADA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 85 CANADA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 86 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 87 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 88 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 89 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 90 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 91 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 92 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 93 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 94 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 95 GERMANY: KEY MACROECONOMIC INDICATORS
  • TABLE 96 GERMANY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 97 GERMANY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 98 GERMANY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 99 GERMANY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 100 GERMANY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 101 GERMANY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 102 GERMANY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 103 GERMANY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 104 UK: KEY MACROECONOMIC INDICATORS
  • TABLE 105 UK: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 106 UK: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 107 UK: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 108 UK: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 109 UK: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 110 UK: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 111 UK: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 112 UK: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 113 FRANCE: KEY MACROECONOMIC INDICATORS
  • TABLE 114 FRANCE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 115 FRANCE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 116 FRANCE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 117 FRANCE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 118 FRANCE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 119 FRANCE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 120 FRANCE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 121 FRANCE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 122 ITALY: KEY MACROECONOMIC INDICATORS
  • TABLE 123 ITALY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 124 ITALY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 125 ITALY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 126 ITALY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 127 ITALY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 128 ITALY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 129 ITALY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 130 ITALY: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 131 SPAIN: KEY MACROECONOMIC INDICATORS
  • TABLE 132 SPAIN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 133 SPAIN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 134 SPAIN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 135 SPAIN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 136 SPAIN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 137 SPAIN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 138 SPAIN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 139 SPAIN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 140 REST OF EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 141 REST OF EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 142 REST OF EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 143 REST OF EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 144 REST OF EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 145 REST OF EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 146 REST OF EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 147 REST OF EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 157 CHINA: KEY MACROECONOMIC INDICATORS
  • TABLE 158 CHINA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 159 CHINA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 160 CHINA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 161 CHINA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 162 CHINA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 163 CHINA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 164 CHINA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 165 CHINA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 166 JAPAN: KEY MACROECONOMIC INDICATORS
  • TABLE 167 JAPAN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 168 JAPAN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 169 JAPAN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 170 JAPAN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 171 JAPAN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 172 JAPAN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 173 JAPAN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 174 JAPAN: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 175 INDIA: KEY MACROECONOMIC INDICATORS
  • TABLE 176 INDIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 177 INDIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 178 INDIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 179 INDIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 180 INDIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 181 INDIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 182 INDIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 183 INDIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 184 AUSTRALIA: KEY MACROECONOMIC INDICATORS
  • TABLE 185 AUSTRALIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 186 AUSTRALIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 187 AUSTRALIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 188 AUSTRALIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 189 AUSTRALIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 190 AUSTRALIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 191 AUSTRALIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 192 AUSTRALIA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 193 SOUTH KOREA: KEY MACROECONOMIC INDICATORS
  • TABLE 194 SOUTH KOREA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 195 SOUTH KOREA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 196 SOUTH KOREA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 197 SOUTH KOREA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 198 SOUTH KOREA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 199 SOUTH KOREA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 200 SOUTH KOREA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 201 SOUTH KOREA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 202 REST OF ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 203 REST OF ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 204 REST OF ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 205 REST OF ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 206 REST OF ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 207 REST OF ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 208 REST OF ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 209 REST OF ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 210 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 211 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 212 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 213 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 214 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 215 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 216 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 217 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 218 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 219 BRAZIL: KEY MACROECONOMIC INDICATORS
  • TABLE 220 BRAZIL: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 221 BRAZIL: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 222 BRAZIL: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 223 BRAZIL: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 224 BRAZIL: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 225 BRAZIL: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 226 BRAZIL: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 227 BRAZIL: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 228 MEXICO: KEY MACROECONOMIC INDICATORS
  • TABLE 229 MEXICO: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 230 MEXICO: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 231 MEXICO: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 232 MEXICO: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 233 MEXICO: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 234 MEXICO: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 235 MEXICO: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 236 MEXICO: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 237 REST OF LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 238 REST OF LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 239 REST OF LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 240 REST OF LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 241 REST OF LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 242 REST OF LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 243 REST OF LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 244 REST OF LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 245 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 246 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 247 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 248 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 249 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 250 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 251 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 252 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 254 GCC COUNTRIES: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR IVF, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 255 GCC COUNTRIES: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
  • TABLE 256 GCC COUNTRIES: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 257 GCC COUNTRIES: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR MEDIA, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 258 GCC COUNTRIES: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET FOR CONSUMABLES, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 259 GCC COUNTRIES: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 260 GCC COUNTRIES: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 261 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, JANUARY 2021–MARCH 2025
  • TABLE 262 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: DEGREE OF COMPETITION
  • TABLE 263 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: REGION FOOTPRINT
  • TABLE 264 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: TYPE FOOTPRINT
  • TABLE 265 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 266 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: PATIENT TYPE FOOTPRINT
  • TABLE 267 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: END-USER FOOTPRINT
  • TABLE 268 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 269 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 270 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025
  • TABLE 271 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 272 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
  • TABLE 273 COOPERSURGICAL INC.: COMPANY OVERVIEW
  • TABLE 274 COOPERSURGICAL INC.: PRODUCTS OFFERED
  • TABLE 275 COOPERSURGICAL INC.: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 276 FUJIFILM IRVINE SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 277 FUJIFILM IRVINE SCIENTIFIC: PRODUCTS OFFERED
  • TABLE 278 FUJIFILM IRVINE SCIENTIFIC: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 279 FUJIFILM IRVINE SCIENTIFIC: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
  • TABLE 280 VITROLIFE: COMPANY OVERVIEW
  • TABLE 281 VITROLIFE: PRODUCTS OFFERED
  • TABLE 282 VITROLIFE: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 283 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 284 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 285 COOK MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 286 COOK MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 287 COOK MEDICAL INC.: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025
  • TABLE 288 COOK MEDICAL INC.: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 289 HAMILTON THORNE: COMPANY OVERVIEW
  • TABLE 290 HAMILTON THORNE: PRODUCTS OFFERED
  • TABLE 291 HAMILTON THORNE: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 292 KITAZATO CORPORATION: COMPANY OVERVIEW
  • TABLE 293 KITAZATO CORPORATION: PRODUCTS OFFERED
  • TABLE 294 KITAZATO CORPORATION: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 295 ESCO MICRO PTE. LTD.: COMPANY OVERVIEW
  • TABLE 296 ESCO MICRO PTE. LTD.: PRODUCTS OFFERED
  • TABLE 297 ESCO MICRO PTE. LTD.: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 298 FERTIPRO NV: COMPANY OVERVIEW
  • TABLE 299 FERTIPRO NV: PRODUCTS OFFERED
  • TABLE 300 GENEA BIOMEDX: COMPANY OVERVIEW
  • TABLE 301 GENEA BIOMEDX: PRODUCTS OFFERED
  • TABLE 302 GENEA BIOMEDX: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 303 LENUS PHARMA GESMBH: COMPANY OVERVIEW
  • TABLE 304 LENUS PHARMA GESMBH: PRODUCTS OFFERED
  • TABLE 305 LENUS PHARMA GESMBH: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025
  • TABLE 306 ZITA WEST: COMPANY OVERVIEW
  • TABLE 307 ZITA WEST: PRODUCTS OFFERED
  • TABLE 308 EXELTIS USA, INC.: COMPANY OVERVIEW
  • TABLE 309 EXELTIS USA, INC.: PRODUCTS OFFERED
  • TABLE 310 VITABIOTICS LTD.: COMPANY OVERVIEW
  • TABLE 311 VITABIOTICS LTD.: PRODUCTS OFFERED
  • TABLE 312 ADVACARE PHARMA: COMPANY OVERVIEW
  • TABLE 313 ADVACARE PHARMA: PRODUCTS OFFERED
  • TABLE 314 FAIRHAVEN HEALTH: COMPANY OVERVIEW
  • TABLE 315 SHANGHAI UNICORN MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 316 GYNEMED GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 317 INVITROCARE INC.: COMPANY OVERVIEW
  • TABLE 318 IVFTECH: COMPANY OVERVIEW
  • TABLE 319 LABIVF ASIA PTE LTD.: COMPANY OVERVIEW
  • TABLE 320 COAST SCIENCE: COMPANY OVERVIEW
  • TABLE 321 BIOIMAGER INC.: COMPANY OVERVIEW
  • TABLE 322 SHIVANI SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 323 MINITÜB GMBH: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: COOPERSURGICAL INC., 2024
  • FIGURE 8 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
  • FIGURE 9 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: DEMAND-SIDE MARKET SIZE ESTIMATION
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2025–2030
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 DATA TRIANGULATION
  • FIGURE 13 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY PATIENT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF ASSISTED REPRODUCTIVE TECHNOLOGY MARKET
  • FIGURE 18 INCREASING INFERTILITY WORLDWIDE TO DRIVE MARKET
  • FIGURE 19 IVF SEGMENT AND CHINA DOMINATED ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET IN 2024
  • FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 21 ASIA PACIFIC TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 22 DEVELOPING MARKETS TO HAVE HIGHER CAGR DURING FORECAST PERIOD
  • FIGURE 23 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 AVERAGE AGE OF FIRST-TIME MOTHERS IN US, 2001–2023
  • FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET
  • FIGURE 26 AVERAGE SELLING PRICE TREND OF SUPPLEMENTS, BY REGION, 2022–2024 (USD)
  • FIGURE 27 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 28 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 30 INVESTMENT AND FUNDING SCENARIO, 2019–2023
  • FIGURE 31 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023
  • FIGURE 32 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)
  • FIGURE 33 PATENT ANALYSIS, JANUARY 2014–DECEMBER 2024
  • FIGURE 34 PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS
  • FIGURE 36 KEY BUYING CRITERIA FOR TOP TWO END USERS
  • FIGURE 37 AI USE CASES
  • FIGURE 38 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF TOP PLAYERS IN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, 2020–2024 (USD MILLION)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, 2024
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
  • FIGURE 43 EV/EBITDA OF KEY VENDORS, 2025
  • FIGURE 44 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 45 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 46 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: COMPANY FOOTPRINT
  • FIGURE 47 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 48 COOPERSURGICAL INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 49 FUJIFILM IRVINE SCIENTIFIC: COMPANY SNAPSHOT (2024)
  • FIGURE 50 VITROLIFE: COMPANY SNAPSHOT (2024)
  • FIGURE 51 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)

This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

Secondary Research

This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the assisted reproductive technology market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the assisted reproductive technology market. Primary sources from the demand side included hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.

A breakdown of the primary respondents for assisted reproductive technology market (supply side) market is provided below:

Assisted Reproductive Technology Market

Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million

Note 2: C-level executives include CEOs, COOs, CTOs, and VPs; other primaries include sales managers, marketing managers, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size for assisted reproductive technology market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for assisted reproductive technology market was calculated using data from three distinct sources, as will be discussed below:

Assisted Reproductive Technology Market

Data Triangulation

The entire market was split up into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.

Approach to derive the market size and estimate market growth.

Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of assisted reproductive technology. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

Market Definition

Assisted Reproductive Technology (ART) deals with medical procedures and techniques designed to address infertility and improve the chances of conception. ART includes all fertility treatments in which eggs or embryos are handled outside the human body. These procedures involve the use of medical technology to assist with fertilization, embryo development, and implantation.

Stakeholders

  • Infertility Treatment Device Manufacturers
  • Research Laboratories
  • Healthcare Service Providers (Hospitals, Fertility Centers, Diagnostic Centers, and Fertility Surgical Clinics)
  • Market Research and Consulting Firms
  • Medical Device Suppliers, Distributors, Channel Partners, and Third-party Suppliers
  • Infertility Associations and Organizations
  • Reproductive Endocrinologists, Andrologists, and Reproductive Surgeons
  • Academic Medical Centers and Universities
  • Business Research and Consulting Service Providers
  • Venture Capitalists and Other Government Funding Organizations

Report Objectives

  • To describe, analyze, and forecast the assisted reproductive technology market by technology, type, patient type, end user, and region
  • To describe and forecast the assisted reproductive technology market for key regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC Countries
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the assisted reproductive technology market
  • To strategically analyze the ecosystem, regulations, patent landscape, trade landscape, and case studies pertaining to the market under study
  • To provide a detailed overview of the supply chain pertaining to the assisted reproductive technology market ecosystem, along with the average selling prices of different types of assisted reproductive technology instruments and consumables
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To profile key players and comprehensively analyze their market shares and core competencies2 in the assisted reproductive technology market
  • To analyze competitive developments such as agreements, acquisitions, and product launches, in the assisted reproductive technology market
  • To analyze the ongoing trend of Al/Gen Al and provide an impact analysis

 

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Assisted Reproductive Technology Market

DMCA.com Protection Status